About EMD Millipore
EMD Millipore is a Healthcare company based in Burlington (United States) founded in 1668, and was acquired by Merck in July 2010. Chemicals are supplied for industrial and laboratory applications. EMD Millipore has completed 1 acquisition, including Cytek Biosciences. EMD Millipore offers products and services including Analytical Chemistry, Cell Culture & Analysis, Filtration Solutions, and Pharma & Biopharma Manufacturing. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity is Merck Group. Its competitors include ANI Pharmaceuticals, Red Nucleus and Caidya; 1 of its 3 listed competitors has raised funding.
Company details
EMD Millipore was established in 1668 and is based in Burlington, United States. Operations focus on the supply of chemicals used in industrial processes and laboratory settings. Products are distributed to support research, manufacturing, and analytical needs across multiple sectors. The company maintains a global presence through its domain emdmillipore.com, serving clients in scientific and industrial fields with essential materials.
- Headquarters Burlington, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website emdmillipore.com
- Social X
- Acquired by Merck (Jul 2010)
- Legal Name Merck Group
- Investors
- Investments & Acquisitions
- Acquired byMerck
(Jul 2010)
Products & Services of EMD Millipore
EMD Millipore offers a comprehensive portfolio of products and services, including Analytical Chemistry, Cell Culture & Analysis, Filtration Solutions, and Pharma & Biopharma Manufacturing.
Tools for testing and analyzing chemicals in labs
Products for cell growth and biological studies
Systems for filtering samples in research applications
Services for drug development and manufacturing
Investors in EMD Millipore
EMD Millipore has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Merck is engaged in science and technology solutions globally. | 1668 | merckgroup.com | Darmstadt, Germany |
Investor details for EMD Millipore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EMD Millipore
99 people are tracked at EMD Millipore (25 in leadership, 74 in team).
| Name | Role | Group |
|---|---|---|
Michal Daniely | Director, Research & Development | Leadership |
Jean-Charles Wirth | Head of Applied Solutions | Leadership |
David Hutchinson | General Counsel & Head of Legal Business Partners | Leadership |
Melissa Stoneman | Director, Global Marketing Communications | Leadership |
Karen Madden | Chief Technology Officer | Leadership |
Paul Ross | Director Of R&d And Technology Development | Leadership |
Matthias Heinzel | CEO | Leadership |
Shaf Yousaf | Chief Marketing Officer | Leadership |
Kasia Gralak McIpd | HR Business Partner | Leadership |
James Wareham | Vice President -global Sales, Inventory & Operational Planning | Leadership |
Bart Kerkman | Chief Information Officer | Leadership |
Tim M. Jaeger | EVP & Chief Strategy & Transformation Officer | Leadership |
Nelda Bonini | Head of Human Resources for Life Science | Leadership |
Gilles Fellous | Senior Director, IT Global Applications | Leadership |
Mark Robillard | VP - R&d | Leadership |
Steve Cecil | Director Strategic Business Development - Analytical | Leadership |
Cheryl Stipsits | Environmental, Health & Safety Director - St. Louis Operations | Leadership |
George Bleazard | Corporate Director - Ehs, Security, Transportation Compliance And Product Safety | Leadership |
Tish Creasey | Vice President, Operations & Marketing | Leadership |
Jo Ann Williams | Director, Marketing Operations | Leadership |
79 more people are available in the full profile.
Complete people profiles for EMD Millipore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EMD Millipore
EMD Millipore has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cytek Biosciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cytek Biosciences is engaged in developing advanced flow cytometry solutions. | amnis.com | Seattle, United States | 1998 | Aug 2011 | •••• |
Complete acquisition details for EMD Millipore
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of EMD Millipore
2 dated milestones of EMD Millipore across 1 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Merck.
- Acquisition Acquires Cytek Biosciences.
Competitors of EMD Millipore
EMD Millipore has 3 listed competitors in our database, 1 of them funded. They include ANI Pharmaceuticals, Red Nucleus and Caidya.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anipharmaceuticals.com | 1996 | Baudette, United States | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | ||
| rednucleus.com | 2014 | Yardley, United States | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | ||
| caidya.com | 2003 | Morrisville, United States | $373M | 351 | CRO focused on clinical development for phases II & III clinical trials and regulatory affair services |
Detailed competitors of EMD Millipore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EMD Millipore
The website of EMD Millipore (emdmillipore.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 26.4% vs previous month
Websites whose visitors overlap most with EMD Millipore. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
enzolifesciences.com | enzolifesciences.com | 100% | – | ||
| scbt.com | 98% | 444.3K | #138,937 | View details | |
| mpbio.com | 98% | 112.2K | #351,727 | View details | |
| caymanchem.com | 95% | 393.1K | #148,469 | View details | |
| 2bscientific.com | 94% | #1,608,543 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for EMD Millipore
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as EMD Millipore (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Emd Millipore
Complete news archive for EMD Millipore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EMD Millipore
EMD Millipore was founded in 1668.
EMD Millipore is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
EMD Millipore was established in 1668 and is based in Burlington, United States. Operations focus on the supply of chemicals used in industrial processes and laboratory settings. Products are distributed to support research, manufacturing, and analytical needs across multiple sectors. The company maintains a global presence through its domain emdmillipore.com, serving clients in scientific and industrial fields with essential materials.
EMD Millipore's top competitors include ANI Pharmaceuticals, Red Nucleus and Caidya.
EMD Millipore offers Analytical Chemistry, Cell Culture & Analysis, Filtration Solutions, and Pharma & Biopharma Manufacturing.
EMD Millipore has made 1 acquisition, including Cytek Biosciences.
EMD Millipore has 1 investor. Key investors include Merck.
EMD Millipore operates through Merck Group.
Yes. EMD Millipore was acquired by Merck in July 2010.